pharmacy

AstraZeneca reports bumper revenue in Q1 2024 on strong drug demand
Business

AstraZeneca reports bumper revenue in Q1 2024 on strong drug demand

Pharmaceutical giant AstraZeneca reported its first quarter 2024 earnings on Thursday, seeing extremely robust earnings per share (EPS) and revenue…
AstraZeneca reports bumper revenue in Q1 2024 on strong drug demand
Business

AstraZeneca reports bumper revenue in Q1 2024 on strong drug demand

Pharmaceutical giant AstraZeneca reported its first quarter 2024 earnings on Thursday, seeing extremely robust earnings per share (EPS) and revenue…
Кнопка «Наверх»
Яндекс.Метрика